Method Validation for the Determination of Nicotine and Nicotine Metabolite Levels in Urine, Serum, and Saliva Samples

Documenti analoghi

• Development and Validation of an LC–MS/MS Method for Quantitative Determination of Tacrolimus in Mouse Serum
  di: Xiaoming Wang, et al.
  Pubblicazione: (2026)
• Quantitative Determination and Stability of Trace Levels of Oxytocin in Human and Rhesus Macaque Urine by LC–MS/MS
  di: Xing Zhang, et al.
  Pubblicazione: (2026)
• A Highly Sensitive Triple Quad LC–MS/MS Method Development and Validation for the Determination of Bexicaserin (LP352) in Human Plasma and Urine Matrices
  di: Raja Reddy Kallem, et al.
  Pubblicazione: (2025)
• A Sensitive and Selective LC–MS/MS‐ESI Method for the Quantitation of Metabolites M9, M12, and M20 of Bexicaserin in Human Plasma and Urine Matrices
  di: Raja Reddy Kallem, et al.
  Pubblicazione: (2025)
• Determination of 59 Psychotropic Drugs, Including Antipsychotics, Antidepressants, Antiepileptics, Anti‐Alcohol Abuse Drugs, Anti‐ADHD Drugs, and Their Metabolites in Urine Using LC–MS/MS for Medication Compliance Monitoring
  di: Jeong Eun Kim, et al.
  Pubblicazione: (2025)